Sign in

CIK 0001885827 · Non-accelerated filer<br>Emerging growth company

Virax Biolabs Group Ltd

Sign in to watch
Ticker
VRAX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Mar 31
Incorporated
Cayman Islands
Entity type
other
Phone
44 020 7788 7414
Business address
BIOCITY GLASGOW, BO'NESS ROAD, NEWHOUSE, LANARKSHIRE, United Kingdom, ML1 5UH
Former names
Virax Biolabs (Cayman) Ltd
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 6-K Event Report of Foreign Issuer
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 6-K Event Report of Foreign Issuer
  13. 424B3 Offering Prospectus
  14. EFFECT Other Notice of Effectiveness
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. F-3 Offering F-3
  17. D Other Notice of Sales of Unregistered Securities
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 2 of 8 · 159 filings